GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Xometry Inc (NAS:XMTR) » Definitions » ROE %

XMTR (Xometry) ROE % : -12.93% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Xometry ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Xometry's annualized net income for the quarter that ended in Sep. 2024 was $-40.8 Mil. Xometry's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was $315.5 Mil. Therefore, Xometry's annualized ROE % for the quarter that ended in Sep. 2024 was -12.93%.

The historical rank and industry rank for Xometry's ROE % or its related term are showing as below:

XMTR' s ROE % Range Over the Past 10 Years
Min: -39.19   Med: -19.89   Max: -15.79
Current: -15.79

During the past 5 years, Xometry's highest ROE % was -15.79%. The lowest was -39.19%. And the median was -19.89%.

XMTR's ROE % is ranked worse than
89.39% of 2950 companies
in the Industrial Products industry
Industry Median: 6.25 vs XMTR: -15.79

Xometry ROE % Historical Data

The historical data trend for Xometry's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xometry ROE % Chart

Xometry Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
- - -39.19 -19.89 -19.28

Xometry Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.20 -12.69 -20.46 -17.22 -12.93

Competitive Comparison of Xometry's ROE %

For the Specialty Industrial Machinery subindustry, Xometry's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xometry's ROE % Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Xometry's ROE % distribution charts can be found below:

* The bar in red indicates where Xometry's ROE % falls into.



Xometry ROE % Calculation

Xometry's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-67.472/( (370.709+329.3)/ 2 )
=-67.472/350.0045
=-19.28 %

Xometry's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %=Net Income (Q: Sep. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Sep. 2024 ))/ count )
=-40.796/( (315.834+315.233)/ 2 )
=-40.796/315.5335
=-12.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.


Xometry  (NAS:XMTR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=-40.796/315.5335
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-40.796 / 566.792)*(566.792 / 678.417)*(678.417 / 315.5335)
=Net Margin %*Asset Turnover*Equity Multiplier
=-7.2 %*0.8355*2.1501
=ROA %*Equity Multiplier
=-6.02 %*2.1501
=-12.93 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=-40.796/315.5335
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-40.796 / -40.676) * (-40.676 / -45.924) * (-45.924 / 566.792) * (566.792 / 678.417) * (678.417 / 315.5335)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.003 * 0.8857 * -8.1 % * 0.8355 * 2.1501
=-12.93 %

Note: The net income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Xometry ROE % Related Terms

Thank you for viewing the detailed overview of Xometry's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xometry Business Description

Traded in Other Exchanges
Address
6116 Executive Boulevard, Suite 800, North Bethesda, MD, USA, 20855
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.
Executives
Peter Goguen officer: Chief Operating Officer 7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
Matthew Leibel officer: Chief Technology Officer 7529 STANDISH PLACE, SUITE 200, CO XOMETRY, INC., DERWOOD MD 20855
Emily Rollins director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
James M Rallo officer: Chief Financial Officer C/O LIQUIDITY SERVICES INC., 1920 L STREET, N.W., 6TH FLOOR, WASHINGTON DC 20036
Bill Cronin officer: Chief Revenue Officer 180 CONCORD DRIVE, MADISON CT 06824
George Hornig director C/O CREDIT SUISSE FIRST BOSTON PRIVATE, 11 MADISON AVE, NEW YORK NY 10010
Katharine Weymouth director 1300 NORTH 17TH STREET, SUITE 1700, ARLINGTON VA 22209
Randolph Altschuler director, officer: Chief Executive Officer 7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
Laurence Zuriff director, officer: Chief Strategy Officer 7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
Kathy Mayerhofer officer: Chief Sales Officer 7529 STANDISH PLACE, SUITE 200, DERWOOD CA 20855
Highland Leaders Fund I, L.p. 10 percent owner ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Leaders Fund I Gp, Llc 10 percent owner ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Leaders Fund I Gp, L.p. 10 percent owner ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Capital Partners 9 Limited Partnership 10 percent owner ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Capital Partners 9-b Limited Partnership 10 percent owner ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142